You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 61, 13 April 2007
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary is posted shortly after the CMEC meeting to give quick advice of certain recommendations made by CMEC to the TGA. The TGA is yet to consider these recommendations and so this summary does not represent final decisions of TGA and should not be taken as such.
Reasons underlying these recommendations will be available after ratification of the Minutes at the next CMEC meeting. Other recommendations may be made at CMEC meetings but, because they concern confidential matters, or matters requiring further consideration by the TGA, they are not available for public disclosure.
Item 2 Confirmation of Draft Minutes of CMEC 60 (16 February 2007)
CMEC confirms that the draft Minutes of its previous meeting (CMEC 60, 16 February 2007), as amended, are a true and accurate record of that meeting.
10.2 Gynaecomastia associated with Lavender and Tea Tree oils
CMEC recommends to the TGA that, based on the evidence presented, the link between exposure to lavender and tea tree oils and prepubertal gynaecomastia is insufficient to warrant any change to the regulatory status of products containing these essential oils.
|Complementary Medicines Evaluation Committee meeting 61 (pdf)||88KB|